Citations

Showing 10 of 108083 citations.

Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options
Alkhawam, Hassan, Patel, Darshan , Nguyen, James , Easaw, Saumya, Al‐Sadawi, Mohammed , Syed, Umer , Zaiem, Feras, Homsi, Maher , Vittorio, Timothy J.

Mayo Clinic

Acta Cardiologica | July 14, 2017 | Volume: 72 | Issue: 4 | Pages: 380-389

10.1080/00015385.2017.1335034 | PMID 28705053 Get It

Imaging and Evaluating the Elastic Properties of Biological Tissues
Greenleaf, JF, Fatemi, Mostafa , Jf, Greenleaf

Mayo Clinic

BMUS Bulletin | July 14, 2017 | Volume: 8 | Issue: 4 | Pages: 16-18

10.1177/1742271x0000800405 Get It

Response by Mulpuru and Shen to Letter Regarding Article, “Selective Modulation of the Cardiac Autonomic Nervous System: A New Strategy for Treatment of Cardioinhibitory Syncope”
Mulpuru, Siva K. , Shen, Win-Kuang

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | July 14, 2017 | Volume: 10 | Issue: 7 | Pages: No page available

10.1161/circep.117.005523 | PMID 28705879 Get It

Rethinking Training and Distribution of Vascular Neurology Interventionists in the Era of Thrombectomy
Grotta, James C. , Lyden, Patrick D. , Brott, Thomas, Lyden, Patrick, Grotta, James C

Mayo Clinic

Stroke | July 14, 2017 | Volume: 48 | Issue: 8 | Pages: 2313-2317

10.1161/strokeaha.116.016416 | PMID 28706124 Get It

Effects of strict prolonged bed rest on cardiorespiratory fitness: systematic review and meta-analysis
Ried‐Larsen, Mathias , Aarts, Hugo M. , Joyner, Michael J. , Joyner, Michael J

Mayo Clinic

Journal of Applied Physiology | July 14, 2017 | Volume: 123 | Issue: 4 | Pages: 790-799

10.1152/japplphysiol.00415.2017 | PMID 28705999 Get It

The aim of this systematic review and meta-analysis [International Prospective Register of Systematic Reviews (PROSPERO) CRD42017055619] was to assess the effects of strict prolonged bed rest (without countermeasures) on maximal oxygen uptake (V̇o2max) and to explore sources of variation therein. Since 1949, 80 studies with a total of 949 participants (>90% men) have been published with data on strict bed rest and V̇o2max. The studies were conducted mainly in young participants [median age (interquartile range) 24.5 (22.4–34.0) yr]. The duration of bed rest ranged from 1 to 90 days. V̇o2max declined linearly across bed rest duration. No statistical difference in the decline among studies reporting V̇o2max as l/min (−0.3% per day) compared with studies reporting V̇o2max normalized to body weight (ml·kg−1·min−1; −0.43% per day) was observed. Although both total body weight and lean body mass declined in response to bed rest, we did not see any associations with the decline in V̇o2max. However, 15–26% of the variation in the decline in V̇o2max was explained by the pre-bed-rest V̇o2max levels, independent of the duration of bed rest (i.e., higher pre-bed-rest V̇o2max levels were associated with larger declines in V̇o2max). Furthermore, the systematic review revealed a gap in the knowledge about the cardiovascular response to extreme physical inactivity, particularly in older subjects and women of any age group. In addition to its relevance to spaceflight, this lack of data has significant translational implications because younger women sometimes undergo prolonged periods of bed rest associated with the complications of pregnancy and the incidence of hospitalization including prolonged periods of bed rest increases with age. NEW & NOTEWORTHY Large interindividual responses of maximal oxygen uptake (V̇o2max) to aerobic exercise training exist. However, less is known about the variability in the response of V̇o2max to prolonged bed rest. This systematic review and meta-analysis showed that pre-bed-rest V̇o2max values were inversely associated with the change in V̇o2max independent of the duration of bed rest. Moreover, we identified a large knowledge gap about the causes of decline in V̇o2max, particularly in postmenopausal women, which may have clinical implications.
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance
Vallapureddy, Rangit, Hoversten, Katherine P., Finke, Christy M. , Ketterling, Rhett P. , Hanson, Curtis A. , Gangat, Naseema , Tefferi, Ayalew , Patnaik, Mrinal M. , Lasho, Terra L. , Hoversten, Katherine, Hanson, Curtis, Patnaik, Mrinal , Ketterling, Rhett P

Mayo Clinic

American Journal of Hematology | July 14, 2017 | Volume: 92 | Issue: 10 | Pages: No page available

10.1002/ajh.24861 | PMID 28707414 Get It

Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver
Campo, Camilo A. , Bookwalter, Candice A., Pay, Andrew J. Van, Hernando, Diego , Schubert, Tilman B. , Reeder, Scott B.

Mayo Clinic

American Journal of Roentgenology | July 13, 2017 | Volume: 209 | Issue: 3 | Pages: 592-603

10.2214/ajr.17.17812 | PMID 28705058 Get It

Comparable Rates of Glucocorticoid‐Associated Adverse Events in Patients With Polymyalgia Rheumatica and Comorbidities in the General Population
Shbeeb, Izzat, Challah, Divya, Raheel, Shafay , Crowson, Cynthia S. , Matteson, Eric L.

Mayo Clinic

Arthritis Care & Research | July 13, 2017 | Volume: 70 | Issue: 4 | Pages: 643-647

10.1002/acr.23320 | PMID 28704600 Get It

ObjectiveTo investigate the use of glucocorticoids (GCs) and related adverse events (AEs) in a long‐term, geographically defined cohort of patients with polymyalgia rheumatica (PMR).MethodsUsing a population‐based inception cohort, details of GC therapy were abstracted from medical records of all patients diagnosed with PMR in 2000–2014. Age‐ and sex‐matched comparators without PMR were identified from the same underlying population. Cumulative and daily dosage of GC, rate of disease relapse, occurrence of GC‐related AEs, and rate of GC discontinuation were analyzed.ResultsThe study included 359 patients with PMR and 359 comparators. The median time to taper below 5 mg/day for 6 months was 1.44 years (95% confidence interval [95% CI] 1.36–1.62), while the median time to permanent discontinuation was 5.95 years (95% CI 3.37–8.88). The mean ± SD cumulative dose of GC at 2 and 5 years was 4.0 ± 3.5 grams and 6.3 ± 9.8 grams, respectively. The mean ± SD daily dose of GC at 2 and 5 years was 6.1 ± 7.6 mg/day and 7.2 ± 9.5 mg/day, respectively. There were no differences in rates of AEs between patients with PMR and comparators for diabetes mellitus, hypertension, hyperlipidemia, or hip, vertebral, or Colles fractures (P > 0.2 for all). Cataracts were more common in patients with PMR than comparators (hazard ratio 1.72 [95% CI 1.23–2.41]).ConclusionRelapse rates in PMR are highest in the early stages of therapy. Despite often protracted therapy, with the exception of cataracts, the rates of studied morbidities linked to GC are not more common in PMR than comparators.
Cryoballoon ablation in Chinese patients with paroxysmal atrial fibrillation: 1‐year follow‐up
Ling, Tianyou , Pan, Wenqi , Lin, Changjian , Lee, Hon‐Chi, Wu, Liqun , Ling, Tian-You , Jin, Qi , Zhang, Ning

Mayo Clinic

Pacing and Clinical Electrophysiology | July 13, 2017 | Volume: 40 | Issue: 10 | Pages: 1067-1072

10.1111/pace.13157 | PMID 28703873 Get It

AbstractObjectivesWe assessed the effectiveness and safety of cryoballoon ablation (CBA) in the Chinese population with paroxysmal atrial fibrillation (AF) with a 1‐year follow‐up and determined the association of early recurrence of atrial tachyarrhythmias (ERAT) with late recurrence (LR).MethodsA total of 114 patients (age 61 ± 10 years, 78 males) with paroxysmal AF who underwent CBA were consecutively enrolled. After procedures, patients were observed for 3 days with continuous electrocardiogram monitoring in the hospital with routine follow‐up visits at 3 months, 6 months, and 1 year. Documented atrial tachyarrhythmia >30 seconds was defined as recurrence. ERAT was defined as any recurrence during the first 3 months, and LR was recurrence between 3 and 12 months.ResultsWith the first 3 months as blanking period, 76% of patients were free of LR at 12 months. Five patients (4%) experienced complications, including phrenic nerve palsy, stroke, and groin complications. Forty‐five percent of patients had ERAT in the first 3 months and 31% of patients had ERAT in the first 3 days. Patients with ERAT had higher LR rate (LRR) than those without ERAT (43% vs 8%, P < 0.001). The LRR of patients with ERAT only in the first 3 days was lower than those with ERAT both in the first 3 days and in 4–90 days (29% vs 64%, P = 0.036).ConclusionsCBA was an effective and safe treatment option for paroxysmal AF. Patients with ERAT had higher LRR after CBA of AF. The time when ERAT occurred had an impact on LRR.
Normal Nasal Resistance
Pallanch, John F., McCaffrey, Thomas V., Kern, Eugene B.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | July 13, 2017 | Volume: 93 | Issue: 6 | Pages: 778-785

10.1177/019459988509300616 | PMID 3937103 Get It

Eighty normal adults without nasal symptoms were studied to determine normal nasal resistance values and the variation of nasal resistance in normal adults. A microprocessor‐based system for collection and analysis of transnasal pressure and flow was used to obtain nasal resistance values. Unilateral and total transnasal pressure and flow values were determined before and after decongestion of the nose with 1% phenylephrine spray. The distribution of the 80 resistance values was found to be skewed to the right. Log transformation of the resistance values was the best method to normalize their distribution. The mean and variation of normal nasal resistance are reported at flows of 0.1 and 0.2 L/sec, at pressures of 0.5 and 1 cm H2O, and at radii of 1, 2, and 3 on the pressure‐flow curve.